Sealed culture vessels and a rack of tubes with in vitro cannabis plantlets on the laboratory bench

What a plant health test report should tell you, and what it cannot

“Tested clean” is the most common claim in cannabis propagation and one of the least informative. It names no tissue, no method, no detection limit, no date and no sample size, which means it cannot be checked, compared or relied on. This article is about how to read a real report, and what an honest one can and cannot promise.

Five things a report has to state

A test result is a measurement, and a measurement without its conditions is an opinion. Ask for these five and treat their absence as the answer.

  • Tissue. Which part of the plant was sampled. This matters more than anything else on the list, for reasons in the next section.
  • Method. RT-PCR or RT-qPCR for viroids. There is no antibody test for HLVd, because it has no coat protein, so anything described as a quick strip test is not testing for the viroid.
  • Detection limit. The lowest quantity the assay reliably reports. Without it, “not detected” has no magnitude.
  • Date, and the plant age. A result is a snapshot. Its value decays, and, as below, a very young plant can be untestable rather than clean.
  • Sample size. How many plants, from how many positions, and whether samples were pooled. A single sample from a batch of five hundred describes one plant.

Why the tissue matters most

HLVd is not evenly distributed inside a plant. Roots carry it most consistently, petioles next, and leaf lamina least reliably. In one comparison on the same plants, fifteen of forty root samples were positive against one of forty leaf samples. A leaf-only protocol on that material would have reported a 2.5 per cent infection rate for a population that was more than a third positive.

There is counter-evidence. A study of one commercial assay reported leaves performing as well as roots. It is worth knowing that the study was authored by the vendor of that assay, and worth noticing that the disagreement itself is the useful information: when specialists disagree about where to sample, sampling one tissue and calling it a clean bill of health is not defensible.

The practical resolution is to sample roots and petioles, from more than one position per plant, and to say so on the report.

Timing, which is where most false negatives come from

After infection, the viroid appears in roots at two to three weeks and in foliage at four to six. Reliable detection starts from roughly five to six weeks of plant age, and the signal keeps strengthening to seven to ten weeks.

Two consequences follow, and both are counterintuitive.

A plantlet tested in its first week tells you very little. It is not old enough to have an interpretable result. And a plant infected a few days before sampling can be genuinely, correctly negative, and positive a month later. That is not a laboratory error. It is what a detection limit means.

This is the whole argument for testing twice, on arrival and again at the end of a four to six week quarantine. One test is a snapshot. Two tests, separated by the latency period, are a conclusion.

Pooling, and the limits of it

Pooling several plants into one reaction is a legitimate screen, and the standard approach is to pool, then retest the individual plants behind any positive pool. What is missing from the literature is a validated maximum pool size for cannabis. A pool large enough dilutes a single infected plant below the detection limit, and nobody has published where that line sits.

If a report mentions pooling, ask for the pool size. If it does not mention pooling, ask whether pooling was used.

The opposite failure: too sensitive

There is a mirror-image problem that gets much less attention. Assays with extremely low detection limits can report RNA fragments that are not infectious, or surface carry-over from a neighbouring sample, and the infectious dose for HLVd is not known. A very low positive is not automatically a plant to destroy.

The better-supported practice is to repeat the test and track the signal strength across tests, rather than culling on a single weak positive. Both kinds of overreaction cost money: throwing out clean plants, and keeping infected ones.

What an honest supplier can promise

It is worth being precise about this, because the industry generally is not.

A test result can tell you: this tissue, from this plant, on this date, by this method, above this detection limit, showed no detectable viroid.

It cannot tell you: that the whole plant is free of it, that an infection acquired in the days before sampling would have shown, that other pathogens were absent unless they were separately tested, or anything at all about the status of the plant after it leaves the laboratory.

That last point is not a disclaimer, it is the operational reality. Once plants are in your facility, their status depends on your irrigation, your tools and your neighbouring rooms. This is why we send an acclimatisation and hygiene guide with every delivery, and why the honest version of a clean-stock claim always comes with a quarantine protocol attached.

The numbers the industry repeats, and where they come from

Two figures circulate constantly: that HLVd costs the industry four billion dollars a year, and that it cuts THC by fifty to seventy per cent. Both are worth handling carefully.

The four billion is arithmetic, not measurement: an assumed one third loss applied to 2021 sales, published by a nursery that sells clean plants. The potency figure has a similar provenance. Controlled work tells a more modest story. A university trial on hemp found no significant loss of biomass, flower or seed yield in symptomatic plants, and a measurable but small decline in cannabinoid content. Work on hops, where the viroid has been studied for far longer, reports cone yield losses of roughly 8 to 37 per cent and alpha acid losses of 15 to 50 per cent, strongly dependent on variety.

The effect is real, and variety and environment decide its size. Anyone quoting a single dramatic percentage for all cannabis is selling something.

A short checklist

Before you accept propagation material:

  • Ask for the batch report, not a certificate
  • Check that it names tissue, method, detection limit, date and sample size
  • Check the plant age at sampling, and be sceptical of anything under five weeks
  • Ask about pooling and pool size
  • Plan your own entry test, and a second one after four to six weeks
  • Keep the batch reference, so a later problem can be traced back

A supplier who welcomes these questions is showing you their process. A supplier who finds them awkward has told you something too.

Sources: Punja et al., Plants 14:830, 2025. Medicinal Genomics, HLVd sampling guidance, 2023. Oregon State University Extension, EM 9570, 2024. Viruses 15:681, 2023, and 15:1487, 2023. Deyle, Colorado State University thesis, 2024.


Related questions in the Help Center

Scroll to Top